Topics:

All Content

A new study clarifies the link between metformin and lung cancer. Perhaps not surprisingly, a smoking habit (or lack of it) substantially affects risk.

It may be difficult to distinguish borderline personality disorder from bipolar, but the difference is crucial for appropriate treatment. A review details the features crucial to correct diagnosis.

Reward processing in the ventral and dorsal striatium is altered in both medicated and nonmedicated bipolar patients, and may distinguish bipolar from unipolar depression.

The transition from Medicaid to Medicare Part D has observable effects on treatment of bipolar.

Common medical conditions frequently complicate bipolar disorder. The purely physical problems often receive more attention and care than the mood disorder.

There is increasing evidence that diabetes or prediabetes may contribute to the risk for bipolar, as well as interfering with treatment effectiveness.

Recovery-focused cognitive behavior therapy is showing promise in reducing recent-onset bipolar disorder.

New research is clarifying the link between brain glutamate levels and risk for psychosis in bipolar, as well as genes associated with the glutamate pathway that are overexpressed in bipolar.

Deficits in dopamine signaling are linked strongly to poor decision making in patients with bipolar. Is it time to stratify treatment based on this understanding?

Three studies investigate patterns of substance abuse among patients with bipolar disorder, and agents that may help.

Pages

By clicking Accept, you agree to become a member of the UBM Medica Community.